BlueWillow Biologics
PrivateLast Round
Grant
Oct 1, 2019
Total Funding Raised
$84.83M
Company Overview
BlueWillow Biologics is a biotechnology company that develops intranasal vaccines and adjuvant technology to protect against infectious diseases and food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueWillow Biologics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BlueWillow Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2019 | ||||
| Grant | Sep 26, 2018 | ||||
| Series A | May 7, 2018 | ||||
| Series C | Nov 28, 2012 | ||||
| Grant | Nov 30, 2010 | ||||
Series B | Jul 8, 2009 |
Key People
Founding team and executive leadership
BlueWillow Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Coast Technology Investors | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| Perseus, L.L.C. | Series B, Private Equity |
| Venture Investors LLC | Series B |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2019
$3.2M grant from National Institute of Allergy and Infectious Diseases.
- Jul 8, 2009
$22M round led by Perseus, L.L.C.
BlueWillow Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BlueWillow Biologics's valuation, stock price, and market status.